Alright that makes more sense and I agree. If a buyout was in the works I don’t believe Paulson would share that with their investors.

Every time a buyout happens most investors are very surprised, so I guess it’s possible. I just don’t see how we would ever get fair value at these prices.

I wouldn’t agree to anything under 10 dollars. Even then I still believe that’s low.

And here come the soft bashers, who are absolutely clueless how much just one indication can be worth.

Immu was one cancer indication which was purchased for 20 Billon!